PhaseBio Pharmaceuticals, Inc.
(NASDAQ : PHAS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.26%139.730.7%$1069.76m
PFEPfizer Inc.
-0.23%42.660.9%$908.48m
MRKMerck & Co., Inc.
0.35%83.070.6%$730.82m
BMYBristol-Myers Squibb Company
1.79%48.411.4%$541.26m
LLYEli Lilly and Company
0.81%112.651.0%$477.49m
ABBVAbbVie, Inc.
0.22%78.862.2%$357.11m
NVSNovartis AG Sponsored ADR
0.49%89.950.2%$198.95m
AZNAstraZeneca PLC Sponsored ADR
0.45%39.851.2%$111.83m
GSKGlaxoSmithKline plc Sponsored ADR
-0.35%39.980.2%$88.84m
NVONovo Nordisk A/S Sponsored ADR Class B
0.76%51.350.1%$74.08m
SNYSanofi Sponsored ADR
0.00%42.470.2%$73.13m
LCILannett Company, Inc.
2.49%5.3536.6%$4.83m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.77%2.201.6%$0.36m
EPIXESSA Pharma Inc
0.88%2.300.1%$0.02m

Company Profile

PhaseBio Pharmaceuticals, Inc. is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.